PORTLAND INVESTMENT COUNSEL INC.
Position in CATX — Perspective Therapeutics, Inc.
CIK 1081668
BURLINGTON, A6
Position in CATX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$852,500
-$190,000 QoQ
Shares Held
250,000
0.0% QoQ
Ownership
0.219%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#37
of 130 holders
Holding Since
Jun 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CATX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026PORTLAND INVESTMENT COUNSEL INC. holds $852,500 across 1 Medical Devices name. CATX ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CATX |
Perspective Therapeutics, Inc.
This page
|
250,000 | $852,500 |
All Filings in CATX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $852,500 | 250,000 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,042,500 | 250,000 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $687,500 | 250,000 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $857,500 | 250,000 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $860,000 | 250,000 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $404,700 | 190,000 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $478,500 | 150,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $934,513 | 70,001 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $697,909 | 70,001 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $407,634 | 342,550 | Shares | Sole | 2024-05-15 | |
| 2023-06-30 | $692,847 | 1,034,100 | Shares | Sole | 2023-08-14 | |
| No filing history on record for this holder in this stock. | ||||||